Obesity is a chronic disease characterized by the abnormal or excessive accumulation of
body fat, affecting more than 1 billion people worldwide. Obesity is commonly associated …

Non-alcoholic fatty liver disease (NAFLD) is currently related to a heavy socioeconomic
burden and increased incidence. Since obesity is the most prevalent risk factor for NAFLD …

The gut microbiome is associated with hepatitis B virus (HBV)-induced liver disease, which
progresses from chronic hepatitis B, to liver cirrhosis, and eventually to hepatocellular …

Obesity promotes triple-negative breast cancer (TNBC), and effective interventions are
urgently needed to break the obesity-TNBC link. Epidemiologic studies indicate that bariatric …

Obesity and type 2 diabetes (T2D) lead to defects in intestinal hormones secretion,
abnormalities in the composition of bile acids (BAs), increased systemic and adipose tissue …

The metabolic benefits of time-restricted eating (TRE) in humans are statistically significant
but not clinically relevant. Few data are available about the effects of TRE on the gut …

Context Qingyi granules can be used to effectively treat patients with severe acute
pancreatitis (SAP). Objective To elucidate the role of gut microbiota-mediated metabolism in …

The Western diet is associated with gastrointestinal dysbiosis, an active contributor to the
pathophysiology of obesity and its comorbidities. Gastrointestinal dysbiosis is strongly linked …

In recent years, there has been a gradual increase in the prevalence of obesity and type 2
diabetes mellitus (T2DM), with bariatric surgery remaining the most effective treatment …

Liver cirrhosis is one of the most prevalent chronic liver disorders with high mortality. We
aimed to explore changed gut microbiome and urine metabolome in compensatory liver …